Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors

Endometrial cancer is the leading gynecologic cancer in women in the United States with 52,630 women predicted to be diagnosed with the disease in 2014. The objective of this study was to determine if progesterone (P4) receptor membrane component 1 (PGRMC1) influenced endometrial cancer cell viabili...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Lett
Autors principals: Friel, Anne M., Zhang, Ling, Pru, Cindy A., Clark, Nicole C., McCallum, Melissa L., Blok, Leen J., Shioda, Toshi, Peluso, John J., Rueda, Bo R., Pru, James K.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4259802/
https://ncbi.nlm.nih.gov/pubmed/25304370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2014.09.036
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars